, Volume 38, Issue 1, pp 126–133 | Cite as

CCR5 Blockade Promotes M2 Macrophage Activation and Improves Locomotor Recovery After Spinal Cord Injury in Mice

  • Fengtao Li
  • Bin Cheng
  • Jian Cheng
  • Dong Wang
  • Haopeng Li
  • Xijing He


Spinal cord injury (SCI) is considered to be primarily associated with loss of motor function and leads to activate diverse cellular mechanisms in the central nervous system to attempt to repair the damaged spinal cord tissue. Chemokine Receptor 5 (CCR5), a major co-receptor for macrophage-tropic human immunodeficiency viruses, is expressed on the surface of monocytes/macrophages, dendritic cells, activated T cells, and NK cells. Recent papers have indicated the important role of CCR5 in SCI, but the mechanism is still unknown. In our current study, CCR5 blockade displayed increased myelin sparring and enhanced SC repair process. The number of CD4+ T cells, CD8+ T cells, Ly6G+ neutrophils and CD11b+ macrophages were all significantly lower in the anti-CCR5 group than that in the control group after SCI. The IL-4 and IL-13 levels in anti-CCR5 group were markedly higher than that in control group after SCI. Correspondingly, the anti-CCR5-treated group showed increased numbers of Arg1- or CD206-expressing macrophages compared with the control IgG group. Furthermore, CCR5 blockade promoted PPARγ activation, and the increased numbers of M2 macrophages induced by CCR5 blockade were both reversed with additional PPARγ antagonist treatment. In conclusion, our present work provides evidence to support the concept that CCR5 blockade promotes M2 macrophage activation and improves locomotor recovery after SCI in mice.


CCR5 M2 macrophage PPARγ SCI 


  1. 1.
    Scott, J.M., D.E. Warburton, D. Williams, S. Whelan, and A. Krassioukov. 2011. Challenges, concerns and common problems: physiological consequences of spinal cord injury and microgravity. Spinal Cord 49: 4–16.CrossRefPubMedGoogle Scholar
  2. 2.
    Thuret, S., L.D. Moon, and F.H. Gage. 2006. Therapeutic interventions after spinal cord injury. Nature Review Neuroscience 7: 628–643.CrossRefGoogle Scholar
  3. 3.
    Nakahara, S., K. Yone, T. Sakou, et al. 1999. Induction of apoptosis signal regulating kinase 1 (ASK1) after spinal cord injury in rats: possible involvement of ASK1-JNK and -p38 pathways in neuronal apoptosis. Journal of Neuropathology and Experimental Neurology 58: 442–450.CrossRefPubMedGoogle Scholar
  4. 4.
    Liu, S., G.L. Ruenes, and R.P. Yezierski. 1997. NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord. Brain Research 756: 160–167.CrossRefPubMedGoogle Scholar
  5. 5.
    Kato, H., G.K. Kanellopoulos, S. Matsuo, et al. 1997. Neuronal apoptosis and necrosis following spinal cord ischemia in the rat. Experimental Neurology 148: 464–474.CrossRefPubMedGoogle Scholar
  6. 6.
    Crowe, M.J., J.C. Bresnahan, S.L. Shuman, J.N. Masters, and M.S. Beattie. 1997. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nature Medicine 3: 73–76.CrossRefPubMedGoogle Scholar
  7. 7.
    Taoka, Y., K. Okajima, M. Uchiba, et al. 1997. Role of neutrophils in spinal cord injury in the rat. Neuroscience 79: 1177–1182.CrossRefPubMedGoogle Scholar
  8. 8.
    Popovich, P.G., Z. Guan, V. McGaughy, L. Fisher, W.F. Hickey, and D.M. Basso. 2002. The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. Journal of Neuropathology and Experimental Neurology 61: 623–633.PubMedGoogle Scholar
  9. 9.
    Pineau, I., and S. Lacroix. 2007. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. Journal of Comparative Neurology 500: 267–285.CrossRefPubMedGoogle Scholar
  10. 10.
    Carlson, S.L., M.E. Parrish, J.E. Springer, K. Doty, and L. Dossett. 1998. Acute inflammatory response in spinal cord following impact injury. Experimental Neurology 151: 77–88.CrossRefPubMedGoogle Scholar
  11. 11.
    Blight, A.R. 2002. Miracles and molecules—progress in spinal cord repair. Nature Neuroscience 5(Suppl): 1051–1054.CrossRefPubMedGoogle Scholar
  12. 12.
    Hausmann, O.N. 2003. Post-traumatic inflammation following spinal cord injury. Spinal Cord 41: 369–378.CrossRefPubMedGoogle Scholar
  13. 13.
    Springer, T.A. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annual Review of Physiology 57: 827–872.CrossRefPubMedGoogle Scholar
  14. 14.
    Flach, R., N. Speidel, S. Flohe, et al. 1998. Analysis of intragraft cytokine expression during early reperfusion after liver transplantation using semi-quantitative RT-PCR. Cytokine 10: 445–451.CrossRefPubMedGoogle Scholar
  15. 15.
    Gu, L., S. Tseng, R.M. Horner, C. Tam, M. Loda, and B.J. Rollins. 2000. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404: 407–411.CrossRefPubMedGoogle Scholar
  16. 16.
    Murphy, P.M., M. Baggiolini, I.F. Charo, et al. 2000. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacological Reviews 52: 145–176.PubMedGoogle Scholar
  17. 17.
    Luster, A.D. 1998. Chemokines—chemotactic cytokines that mediate inflammation. New England Journal of Medicine 338: 436–445.CrossRefPubMedGoogle Scholar
  18. 18.
    Kiguchi, N., Y. Kobayashi, T. Maeda, F. Saika, and S. Kishioka. 2010. CC-chemokine MIP-1alpha in the spinal cord contributes to nerve injury-induced neuropathic pain. Neuroscience Letters 484: 17–21.CrossRefPubMedGoogle Scholar
  19. 19.
    Ma, M., T. Wei, L. Boring, I.F. Charo, R.M. Ransohoff, and L.B. Jakeman. 2002. Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion. Journal of Neuroscience Research 68: 691–702.CrossRefPubMedGoogle Scholar
  20. 20.
    Scheff, S.W., A.G. Rabchevsky, I. Fugaccia, J.A. Main, and J.J. Lumpp. 2003. Experimental modeling of spinal cord injury: characterization of a force-defined injury device. Journal of Neurotrauma 20: 179–193.CrossRefPubMedGoogle Scholar
  21. 21.
    Chawla, A., Y. Barak, L. Nagy, D. Liao, P. Tontonoz, and R.M. Evans. 2001. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nature Medicine 7: 48–52.CrossRefPubMedGoogle Scholar
  22. 22.
    Basso, D.M., L.C. Fisher, A.J. Anderson, L.B. Jakeman, D.M. McTigue, and P.G. Popovich. 2006. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. Journal of Neurotrauma 23: 635–659.CrossRefPubMedGoogle Scholar
  23. 23.
    Chen, K.B., K. Uchida, H. Nakajima, et al. 2011. Tumor necrosis factor-alpha antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury. Spine (Phila Pa 1976) 36: 1350–1358.CrossRefGoogle Scholar
  24. 24.
    Uchida, K., H. Baba, Y. Maezawa, and C. Kubota. 2002. Progressive changes in neurofilament proteins and growth-associated protein-43 immunoreactivities at the site of cervical spinal cord compression in spinal hyperostotic mice. Spine (Phila Pa 1976) 27: 480–486.CrossRefGoogle Scholar
  25. 25.
    Saiwai, H., Y. Ohkawa, H. Yamada, et al. 2010. The LTB4-BLT1 axis mediates neutrophil infiltration and secondary injury in experimental spinal cord injury. American Journal of Pathology 176: 2352–2366.CrossRefPubMedCentralPubMedGoogle Scholar
  26. 26.
    Stirling, D.P., and V.W. Yong. 2008. Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry. Journal of Neuroscience Research 86: 1944–1958.CrossRefPubMedGoogle Scholar
  27. 27.
    Goerdt, S., and C.E. Orfanos. 1999. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10: 137–142.CrossRefPubMedGoogle Scholar
  28. 28.
    Odegaard, J.I., R.R. Ricardo-Gonzalez, M.H. Goforth, et al. 2007. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447: 1116–1120.CrossRefPubMedCentralPubMedGoogle Scholar
  29. 29.
    Suzuki, Y., J. Claflin, X. Wang, A. Lengi, and T. Kikuchi. 2005. Microglia and macrophages as innate producers of interferon-gamma in the brain following infection with Toxoplasma gondii. International Journal of Parasitology 35: 83–90.CrossRefPubMedGoogle Scholar
  30. 30.
    Makela, J., R. Koivuniemi, L. Korhonen, and D. Lindholm. 2010. Interferon-gamma produced by microglia and the neuropeptide PACAP have opposite effects on the viability of neural progenitor cells. PloS One 5: e11091.CrossRefPubMedCentralPubMedGoogle Scholar
  31. 31.
    Pouliot, P., V. Turmel, E. Gelinas, M. Laviolette, and E.Y. Bissonnette. 2005. Interleukin-4 production by human alveolar macrophages. Clinical and Experimental Allergy 35: 804–810.CrossRefPubMedGoogle Scholar
  32. 32.
    Shin, W.H., D.Y. Lee, K.W. Park, et al. 2004. Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo. Glia 46: 142–152.CrossRefPubMedGoogle Scholar
  33. 33.
    Popovich, P.G., P. Wei, and B.T. Stokes. 1997. Cellular inflammatory response after spinal cord injury in Sprague–Dawley and Lewis rats. Journal of Comparative Neurology 377: 443–464.CrossRefPubMedGoogle Scholar
  34. 34.
    Stout, R.D., C. Jiang, B. Matta, I. Tietzel, S.K. Watkins, and J. Suttles. 2005. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. Journal of Immunology 175: 342–349.CrossRefGoogle Scholar
  35. 35.
    Martinez, F.O., L. Helming, and S. Gordon. 2009. Alternative activation of macrophages: an immunologic functional perspective. Annual Review of Immunology 27: 451–483.CrossRefPubMedGoogle Scholar
  36. 36.
    Bouhlel, M.A., B. Derudas, E. Rigamonti, et al. 2007. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metabolism 6: 137–143.CrossRefPubMedGoogle Scholar
  37. 37.
    Kigerl, K.A., J.C. Gensel, D.P. Ankeny, J.K. Alexander, D.J. Donnelly, and P.G. Popovich. 2009. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. Journal of Neuroscience 29: 13435–13444.CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Fengtao Li
    • 1
  • Bin Cheng
    • 1
  • Jian Cheng
    • 1
  • Dong Wang
    • 1
  • Haopeng Li
    • 1
  • Xijing He
    • 1
  1. 1.Orthopedics Department TwoThe Second Affiliated Hospital of Xi’an Jiaotong UniversityXi AnChina

Personalised recommendations